Suzuki K - Search Results

1

Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway.

Fueyo J, Alemany R, Gomez-Manzano C, Fuller GN, Khan A, Conrad CA, Liu TJ, Jiang H, Lemoine MG, Suzuki K, Sawaya R, Curiel DT, Yung WK, Lang FF. Fueyo J, et al. Among authors: suzuki k. J Natl Cancer Inst. 2003 May 7;95(9):652-60. doi: 10.1093/jnci/95.9.652. J Natl Cancer Inst. 2003. PMID: 12734316

2

A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency.

Suzuki K, Fueyo J, Krasnykh V, Reynolds PN, Curiel DT, Alemany R. Suzuki K, et al. Clin Cancer Res. 2001 Jan;7(1):120-6. Clin Cancer Res. 2001. PMID: 11205899

3

Treatment of ovarian cancer with a tropism modified oncolytic adenovirus.

Bauerschmitz GJ, Lam JT, Kanerva A, Suzuki K, Nettelbeck DM, Dmitriev I, Krasnykh V, Mikheeva GV, Barnes MN, Alvarez RD, Dall P, Alemany R, Curiel DT, Hemminki A. Bauerschmitz GJ, et al. Among authors: suzuki k. Cancer Res. 2002 Mar 1;62(5):1266-70. Cancer Res. 2002. PMID: 11888888

4

The presence of the adenovirus E3 region improves the oncolytic potency of conditionally replicative adenoviruses.

Suzuki K, Alemany R, Yamamoto M, Curiel DT. Suzuki K, et al. Clin Cancer Res. 2002 Nov;8(11):3348-59. Clin Cancer Res. 2002. PMID: 12429621

5

Blood clearance rates of adenovirus type 5 in mice.

Alemany R, Suzuki K, Curiel DT. Alemany R, et al. Among authors: suzuki k. J Gen Virol. 2000 Nov;81(Pt 11):2605-2609. doi: 10.1099/0022-1317-81-11-2605. J Gen Virol. 2000. PMID: 11038370

6

[Viral therapy of cancer].

Suzuki K, Curiel DT. Suzuki K, et al. Rev Invest Clin. 2001 Jul-Aug;53(4):346-56. Rev Invest Clin. 2001. PMID: 11599483 Review. Spanish.

7

Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus.

Kanerva A, Zinn KR, Chaudhuri TR, Lam JT, Suzuki K, Uil TG, Hakkarainen T, Bauerschmitz GJ, Wang M, Liu B, Cao Z, Alvarez RD, Curiel DT, Hemminki A. Kanerva A, et al. Among authors: suzuki k. Mol Ther. 2003 Sep;8(3):449-58. doi: 10.1016/s1525-0016(03)00200-4. Mol Ther. 2003. PMID: 12946318 Free article.

8

A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P-MAPK-selective mRNA stabilization.

Ahmed A, Thompson J, Emiliusen L, Murphy S, Beauchamp RD, Suzuki K, Alemany R, Harrington K, Vile RG. Ahmed A, et al. Among authors: suzuki k. Nat Biotechnol. 2003 Jul;21(7):771-7. doi: 10.1038/nbt835. Epub 2003 Jun 8. Nat Biotechnol. 2003. PMID: 12794639

9

Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo.

Rivera AA, Wang M, Suzuki K, Uil TG, Krasnykh V, Curiel DT, Nettelbeck DM. Rivera AA, et al. Among authors: suzuki k. Virology. 2004 Mar 1;320(1):121-34. doi: 10.1016/j.virol.2003.11.028. Virology. 2004. PMID: 15003868 Free article.

10

Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapy.

Lam JT, Kanerva A, Bauerschmitz GJ, Takayama K, Suzuki K, Yamamoto M, Bhoola SM, Liu B, Wang M, Barnes MN, Alvarez RD, Siegal GP, Curiel DT, Hemminki A. Lam JT, et al. Among authors: suzuki k. J Gene Med. 2004 Dec;6(12):1333-42. doi: 10.1002/jgm.635. J Gene Med. 2004. PMID: 15493039

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19,184 results

Search Page